advisorsecurities master

ALECAlector, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
11564
Ticker
ALEC
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2019-02-07
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
ALEC

Detail

Enriched 2026-08-14 20:47

Market cap
$240,062,375.85
Shares outstanding (class)
111,656,919
Shares outstanding (weighted)
111,656,919
SIC
2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
103
Location
SOUTH SAN FRANCISCO, CA
Description

Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data